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Therole of fever in host defense, ifindeed it has one, is poorly understood. Fever in response
to exogenous agents is mediated by a host macrophage product called endogenous pyrogen
(EP). Recently it has been shown that EP is probably identical to interleukin I (ILI), an im-
munostimulatory macrophage product that induces T-cell proliferation. We postulated that
the pyrogenic and immunostimulatory actions of this host mediator might be interrelated and
tested T-cell proliferation induced by ILI at a temperature characteristic of fever.
The T-cell proliferative response to ILl (and to the lymphokine, interleukin 2) was greatly
increased at 39'C compared to 37'C, while B-cell mitogenesis in response to lipopolysac-
charide was not. These findings suggest that, ifsimilar events occur in vivo, fever may have im-
portant immunoregulatory significance and call into question the current indiscriminate use of
antipyretic agents.
INTRODUCTION
Our understanding of the pathogenesis of fever has advanced considerably in re-
cent years, but the question of what the mammalian host gains by this metabolically
costly response to infection remains largely unanswered [1,2]. Fever caused by most
exogenous agents is mediated by a hormone-like polypeptide produced by host
macrophages or monocytes. This mediator, called endogenous pyrogen (EP), pro-
duces a controlled rise in body temperature through an action on the thermoregula-
tory area of the brain [3].
Interleukin 1 (ILl - formerly called Lymphocyte Activating Factor) is a peptide of
macrophage origin that stimulates T-lymphocyte proliferation in the presence of lec-
tin or antigen and so enhances, or may even be essential for, immune responses
[4,5,6]. The mitogenic action of ILI on T cells is probably mediated by the lympho-
cyte product interleukin 2 (IL2) [7]. There is now substantial evidence, based on
functional and biochemical properties, to indicate that EP and ILl are iden-
tical [8,9].
We postulated that the pyrogenic and T-cell mitogenic properties of this macro-
phage-derived mediator (EP/ILI) may be functionally interrelated and tested the ef-
fect of increased temperature on T-cell proliferation stimulated by ILI or IL2. We
found that T-cell proliferation in response to either ILl or IL2 in the presence of
concanavalin A (Con A) was greatly increased at 39°C compared to 37°C, while
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B-cell proliferation stimulated by lipopolysaccharide (LPS) was not. Therefore ILI,
the endogenous mediator of fever, also stimulated T-cell proliferation that was
highly temperature-dependent over the range of temperature characteristic of natu-
ral fever. These findings suggest a potentially important immunoregulatory function
of the fever response.
MATERIALS AND METHODS
ILl was prepared by stimulating P388D1 macrophage-like murine tumor cells
with LPS (20 ,g/ml, E. coli, Difco) for four days [10]. Supernatants were precipi-
tated with 65 percent saturated ammonium sulphate, dialyzed against phosphate-
buffered saline and fractionated by gel filtration chromatography over G75 Super-
fine Sephadex (Pharmacia). ILI activity was found in the 15-20,000 MW fractions
and stored at -20°C until used. The final concentrations of ILl used were 0.2, 1,
and 5 percent by volume, corresponding to 5, 25, and 125 units/ml, approximately
[11]. Crude human ILl-containing supernatants from LPS-stimulated blood mono-
cytes were also tested.
IL2 was obtained from the T-cell hybridoma FS6-14.13 [12]. Hybridoma cells
were cultured with Con A (2Ag/ml) for 24 hours (in the absence of serum), and the
supernatants were checked for IL2 activity by maintenance of Con A-induced blast
cells [13] or maintenance of the IL2-dependent T-cell line HT-2 [14] (HT-2 cell line
was a gift ofDr. John Ryan, New Haven, CT, and FS6-14.13 hybridoma was kindly
donated by Drs. J. Kappler and P. Marrack, Denver, CO). Crude IL2-containing
supernatants from Con A-stimulated (5 ,tg/ml) rat spleen cells were also used.
Proliferation assays were performed with thymocytes or spleen cells from C3H/
HeJ (LPS-hyporesponsive) mice or spleen cells from C57BL/6J (LPS-responders).
Cells were cultured in 200 j1 RPMI with 10 percent fetal calf serum in microtiter
wells with different concentrations of ILl or IL2 and Con A for two or three days at
370 or 39°C, and then assayed for proliferation by uptake of tritiated thymidine
following a five-hour pulse with 1 ytCi 3H thymidine (performed at 37°C in all
cases-for details, see figure legends). The proliferative responses ofC57BL6 spleen
cells stimulated with LPS (E. coli) were assayed in the same way. All cultures were
performed in gas-tight boxes within thermostatically controlled incubators ( 0.2QC).
The boxes were flushed with a 10 percent CO2, 90 percent air mixture for two min-
utes daily. Cell viability following culture was assessed by trypan-blue exclusion.'
RESULTS
Thymocyte Proliferation
Thymocyte proliferation induced by murine ILl or IL2 (Fig. 1) or human ILl in
the presence of Con A is greatly increased by culture at 39°C. In ten experiments
with ILl and eight with IL2, the increases were between four- and tenfold. When
thymocyte proliferation was stimulated by human ILI alone (in the absence of Con
A), culture at 39°C resulted in up to sixfold augmentation ofproliferation (data not
shown).
Splenic T-Cell Proliferation
Splenic T-cell proliferation induced by either murine ILl (P388Dl) or IL2
'Thymic cell cultures with Con A and ILl showed 33 percent viability after three days at 37°C and 26
percent viability after three days at 39°C. There were many more blast cells in the 39°C cultures (20 per-
cent of all viable cells compared with 5 percent in 37°C cultures).
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FIG. 1. The proliferative responses (mean + SE oftriplicates) ofthymocytes (1 x 106 in 200Al) from
C3H/HeJ mice, cultured at either 37°C or 39°C for three days with increasing concentrations of murine
ILI (A) or IL2-containing supernatant (B) in the presence of Con A (2 yg/ml) in all cultures.
(FS6-14.13) plus the T-cell mitogen, Con A, was also increased at the higher
temperature (Fig. 2), but the maximum increases (four- to fivefold in eight exper-
iments) were usually lower than those that occurred with thymocytes.
Splenic B-Cell Proliferation and Kinetics ofResponse
To test the possibility that the proliferation of any type of lymphocyte may be in-
creased at 39°C, we examined the mitogenic response of splenic B-cells to the poly-
clonal B-cell mitogen, LPS. At 39°C, LPS-induced, B-cell proliferation (assayed on
day 3) was consistently reduced compared to the responses obtained at 37°C(Fig. 3).
For comparison, the proliferative responses of the same spleen cells (T-cell
responses) to ILI and Con A in the same experiment are also shown (Fig. 3). In eight
experiments, LPS-induced, B-cell proliferation at three days was reduced at 39°C
compared to 37°C. The maximum response of splenic B-cells to LPS at 37°C oc-
curred variably on either the second or third day of culture (upper panel ofTable 1
shows a three-day maximum). In either case, proliferation increased only modestly,
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FIG. 3. The proliferative responses (mean SE of triplicates) of spleen cells (5 x 104 in 200Al) from
C57BL/6J mice cultured at either 370C or 390C for three days with murine ILl and Con A (2 ,g/ml) (A)
or with the B-cell mitogen, LPS (B).
if at all, at 39°C and only on the day preceding the peak response (never more than
twofold). The response of splenic T-cells (in the same experiment) to ILI and Con
A is. shown for comparison in Table 1. The responses ofthymic cells to ILI at 37°C
were usually greatest when tested after three days of culture (being significantly
TABLE 1
Effects of Temperature and Duration of Culture on B- and T-Cell Proliferation
Temperature
370C 390C
Cells Mitogen Day 2 Day 3 Day 2 Day 3
Spleena LPS (jug/ml)
10 16.5(l.8)b 37.7(2.3) 33.3(4.2) 37.3(1.2)
25 22.1(1.1) 62.9(3.3) 37.2(1.4) 65.4(4.8)
50 24.8(4.2) 57.2(5.2) 40.5(2.4) 40.2(3.4)
100 45.1(3.7) 117.0(2.9) 70.6(1.4) 86.7(4.9)
ILl (volOo)c
1 15.0(0.8) 35.7(2.7) 75.2(6.5) 179(7.9)
Thymusd ILl (vol%)C
1 3.5(0.1) 14.2(0.6) 18.8(0.9) 69.8(12)
5 6.0(0.5) 19.3(1.4) 28.6(6.7) 92.6(12)
25 4.6(1.1) 12.1(1.3) 14.3(0.6) 44.0(7.3)
aC57BL/6J, 5 x 104/200 1u/well
bcounts per minute x 10-3, means of triplicates with standard errors in parentheses (controls without
mitogen were less than 1.5 x 103 cpm throughout)
Cmurine ILI with Con A 2 Ag/ml
dC3H/HeJ, 1 x 106/200 il/well
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reduced by the fourth day). The augmenting effect of hyperthermia on two-day
cultures is seen in Table 1 (bottom panel). Culture of T-cells at 39°C did not change
the day of maximum response (day 3), indicating a temperature-dependent augmen-
tation of the total proliferative response ofT cells to ILI rather than an acceleration
of response. These findings demonstrate that, at least with the mitogens used, the
marked augmenting effect of raised temperature on lymphocyte proliferation was
selective for T cells.
DISCUSSION
Beneficial effects ofhyperthermia on lymphocyte proliferation in response to lec-
tins or antigen have been described previously [15,16,17] and we have summarized
some of the findings described here in a short preliminary report [18]. We now
report that T-cell proliferation induced by either ILI, the "endogenous pyrogen," or
the lymphokine mediator, IL2, is greatly increased by hyperthermia.
Since IL2-induced T-cell proliferation was augmented by the higher temperature,
the effect of hyperthermia on IL1-induced proliferation cannot be attributed solely
to increased production of IL2 but is likely to be, at least in part, a property of the
T-cell subset that proliferates in response to IL2.
The temperatures used in these experiments correspond to the normal body
temperature of the resting mouse (37°C) and the temperature of mice during fever
produced by an exogenous pyrogen (LPS) or human endogenous pyrogen (39°C)
([19] and Duff GW, Stitt J, Durum SK, unpublished observations).
It seems, therefore, that the mitogenic action of ILI that causes clonal expansion
of T lymphocytes is greatly increased at higher temperatures, such as those that oc-
cur in natural fevers. Moreover, the production of fever itself is governed by the cen-
tral nervous system in response to a direct or indirect signal provided by ILl [3].
This functional interaction of these two biological properties of ILl, pyrogenicity
and T-cell mitogenicity, could have important immunoregulatory consequences
depending upon the subsets of T cells involved. We have found, for example, that
hyperthermia dramatically improves the primary in vitro humoral immune response.
This augmentation appears to result from an increased generation of T helper cells
rather than enhanced B-cell activation or impaired T suppressor cell function ([20]
and Jampel HD, Duff GW, Gershon RK, et al., submitted for publication).
Our current objectives include the characterization, by membrane phenotype and
lymphokine production, of T-cell subsets affected by hyperthermia and the identifi-
cation of relevant temperature-dependent biochemical events. We have already
reported a marked, rapid effect of hyperthermia on T-cell protein synthesis [21].
Fever, as a host defense, has recently been reviewed by several authors [2,22,23]
and has been shown to correlate both with survival [24,25] and with the development
of an earlier tissue inflammatory response in infected animals [26]. If naturally oc-
curring fever influences the immune response in vivo to the extent suggested by our
observations in vitro, then the role of fever as a host defense may warrant further
examination. For example, antipyretic drugs may be useful in auto-immune diseases
where the immune response is detrimental to the host; but when the immune
response is to the host's advantage (e.g., directed against infections or neoplastic
cells), then fever may itself be beneficial.
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